Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-31 @ 8:49 PM
Study NCT ID:
NCT03391934
Status:
RECRUITING
Last Update Posted:
2023-04-05
First Post:
2017-12-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer
Sponsor:
Cinnagen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-31
First Submit QC Date:
None
Study First Post Date:
2018-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-03
Last Update Post Date:
2023-04-05
Last Update Post Date Type:
ACTUAL